| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 07/18/2001 | EP1115876A2 Receptor based antagonists and methods of making and using |
| 07/18/2001 | EP1115875A1 Human complement c3-degrading polypeptide from streptococcus pneumoniae |
| 07/18/2001 | EP1115874A2 Alzheimer's disease secretase |
| 07/18/2001 | EP1115865A2 Atp binding cassette genes and proteins for diagnosis and treatment of lipid disorders and inflammatory diseases |
| 07/18/2001 | EP1115864A2 Human chaperone proteins |
| 07/18/2001 | EP1115863A1 Ucp4 |
| 07/18/2001 | EP1115862A2 Cytokine receptor zalpha11 |
| 07/18/2001 | EP1115860A2 Membrane-associated organizational proteins |
| 07/18/2001 | EP1115859A2 Hairpin hybridizer molecules for modulation of gene expression |
| 07/18/2001 | EP1115857A1 Use of specific hybrid promoters for controlling tissue expression |
| 07/18/2001 | EP1115848A1 Dna polymerase having ability to reduce innate selective discrimination against fluorescent dye-labeled dideoxynucleotides |
| 07/18/2001 | EP1115843A1 Method for preparing a mixture of starch branching enzymes extracted from algae |
| 07/18/2001 | EP1115735A1 31 human secreted proteins |
| 07/18/2001 | EP1115734A1 Method of measuring protein-protein interactions in living cells |
| 07/18/2001 | CN1304454A Novel nucleic acids and polypeptides related to farnesyl-directed endopeptidase |
| 07/18/2001 | CN1304453A Vaccine-induced hepatitis B viral strain and uses thereof |
| 07/18/2001 | CN1304450A Novel insulin analogs with enhanced zinc binding |
| 07/18/2001 | CN1304446A Poly (ADP-ribose) polymerse gene |
| 07/18/2001 | CN1304442A Delivery of proteins into eukaryotic cells with recombinant Yersinia |
| 07/18/2001 | CN1304317A Nucleic acid encoding hyaluronan synthase and method of use |
| 07/18/2001 | CN1303928A Complex of cytochrome c oxidase |
| 07/18/2001 | CN1303923A Medicinal mycelial fungus Agaricus blazei liquid culture |
| 07/18/2001 | CN1303921A Continuous ferment process |
| 07/17/2001 | USRE37287 Chimeric gene for the transformation of plants |
| 07/17/2001 | US6262247 Polycyclic aromatic hydrocarbon induced molecules |
| 07/17/2001 | US6262244 Genes coding for the extracellular part of four specific nkg2 (natural killer) transmembrane proteins; useful in treating infectious diseases and cancer |
| 07/17/2001 | US6262237 Contacting protocadherin-encoding polynucleotide sequence with antibody (monoclonal, polyclonal, chimeric or humanized) antagonizes homophilic binding; useful for intercellular adhesion |
| 07/17/2001 | US6262233 Tissue factor pathway inhibitor-3 |
| 07/17/2001 | US6262232 Recombinant C-terminal α-amidating enzyme |
| 07/17/2001 | US6262018 Hypersensitive response elicitor from Erwinia amylovora and its use |
| 07/17/2001 | US6262016 Transferrin receptor genes |
| 07/17/2001 | US6261839 Method for the induction of a NK cell-mediated immune response |
| 07/17/2001 | US6261827 Recombinant filamentous fungal cell having regulatory sequences which control expression of heme biosynthetic enzyme or enzymes; industrial production |
| 07/17/2001 | US6261824 Gram negative coccoid bacterium okadaella gastrococcus |
| 07/17/2001 | US6261820 Fibronolytically active polypeptide |
| 07/17/2001 | US6261818 Nucleotide sequence of cardiac-related ankyrin-repeat protein kinase; antisense agents; probes; primers; vectors; host cells; antibodies; diagnosis and treatment of cardiovascular disorders |
| 07/17/2001 | US6261817 Guaa |
| 07/17/2001 | US6261810 Enzymatic oxidative deamination process |
| 07/17/2001 | US6261807 Method for preparing a recombinant adenovirus genome |
| 07/17/2001 | US6261803 Process for preparing functional recombinant tissue factor |
| 07/17/2001 | US6261802 Ups (ugc) |
| 07/17/2001 | US6261801 Nucleic acids encoding tumor necrosis factor receptor 5 |
| 07/17/2001 | US6261606 Naturally extracted and synthetic hypoglycemic or hypolipidemic compositions |
| 07/17/2001 | US6261568 Genetic engineering |
| 07/17/2001 | US6261559 Inhalation device |
| 07/17/2001 | US6261558 Synthetic human neutralizing monoclonal antibodies to human immunodeficiency virus |
| 07/17/2001 | US6261548 Polypeptides for leukemia inhibitor factors with amino acid sequences |
| 07/17/2001 | CA2042054C Cloning and expression of microbial phytase |
| 07/13/2001 | CA2328583A1 New nucleotide sequences coding for the ptsh gene |
| 07/12/2001 | WO2001049870A1 Method for making insulin precursors and insulin precursor analogues having improved fermentation yield in yeast |
| 07/12/2001 | WO2001049866A1 Di- or oligomer of a dimer, trimer, quatromer or pentamer of recombinant fusion proteins |
| 07/12/2001 | WO2001049865A1 Fermentative production of ethanol by heterologous expression of a pyruvate decarboxylase gene in bacillus sp |
| 07/12/2001 | WO2001049859A1 Trichoderma reesei xylanase |
| 07/12/2001 | WO2001049854A2 Increased lysine production by gene amplification using coryneform bacteria |
| 07/12/2001 | WO2001049833A2 Recombinant pinoresinol/lariciresinol reductase, recombinant dirigent protein, and methods of use |
| 07/12/2001 | WO2001049832A2 Transduction of recombinases for inducible gene targeting |
| 07/12/2001 | WO2001049828A1 Mutated hepatitis b virus, its nucleic and protein constituents and uses thereof |
| 07/12/2001 | WO2001049742A1 Method for making insulin precursors and insulin precursor analogs |
| 07/12/2001 | WO2001049740A1 Novel fgf homolog zfgf12 |
| 07/12/2001 | WO2001049715A2 Methods and compositions for inhibiting neoplastic cell growth |
| 07/12/2001 | WO2001049711A2 Nucleic acids encoding (poly)peptides having chips activity |
| 07/12/2001 | WO2001049112A2 Oocyte vitrification technique |
| 07/12/2001 | WO2001012665A3 Helical cytokine zalpha48 |
| 07/12/2001 | WO2001004281A3 Dna coding for beta-tubulin and use thereof |
| 07/12/2001 | WO2001004151A3 TUBERCULOSIS VACCINE AND DIAGNOSTICS BASED ON THE MYCOBACTERIUM TUBERCULOSIS esat-6 GENE FAMILY |
| 07/12/2001 | WO2001002588A3 Generation of specific binding partners binding to (poly)peptides encoded by genomic dna fragments or ests |
| 07/12/2001 | WO2000075278A9 Gene encoding nade, p75ntr-associated cell death executor and uses thereof |
| 07/12/2001 | WO2000074722A3 Modification of biological elements |
| 07/12/2001 | WO2000040736A9 Molecular-biological marker for analytical electron microscopy |
| 07/12/2001 | WO2000034447A8 Human ubiquitin ligase e3 for the modulation of nf-kappa b |
| 07/12/2001 | WO2000004041A3 Methods and molecules relating to cd39-like polypeptides |
| 07/12/2001 | WO2000000510A3 Growth factor modulators |
| 07/12/2001 | US20010007761 Novel process for the isolation of clavulanic acid and of pharmaceutically acceptable salts thereof |
| 07/12/2001 | US20010007752 Genetic engineering; nucleic acids |
| 07/12/2001 | US20010007746 Immobilization |
| 07/12/2001 | DE19963859A1 Bi- oder Oligomer eines Di-, Tri-, Quattro- oder Pentamers von rekombinanten Fusionsproteinen Bi- or oligomer of a di-, tri-, Quattro or pentamer of recombinant fusion proteins |
| 07/12/2001 | DE19963485A1 Verfahren zur Herstellung von Hydroxylnitril-Lyasen A process for preparing Hydroxylnitril lyases |
| 07/12/2001 | DE19963126A1 Verfahren zur Herstellung von 6-O-alpha-D-Glucopyranosyl-D-sorbit A process for the preparation of 6-O-alpha-D-glucopyranosyl-D-sorbitol |
| 07/12/2001 | DE10064713A1 Preparation of gamma-poly(glutamic acid) using Bacillus species, useful e.g. in foods or cosmetics, includes pH adjustment, centrifuging, concentration and alcohol precipitation |
| 07/12/2001 | CA2654770A1 Increased lysine production by gene amplification |
| 07/12/2001 | CA2396798A1 Recombinant pinoresinol/lariciresinol reductase, recombinant dirigent protein, and methods of use |
| 07/12/2001 | CA2396401A1 Novel fgf homolog zfgf12 |
| 07/12/2001 | CA2396219A1 Oocyte vitrification technique |
| 07/12/2001 | CA2396149A1 Transduction of recombinases for inducible gene targeting |
| 07/12/2001 | CA2395876A1 Nucleic acids encoding (poly)peptides having chips activity |
| 07/12/2001 | CA2392844A1 Method for making insulin precursors and insulin precursor analogues having improved fermentation yield in yeast |
| 07/11/2001 | EP1114867A1 Transcription regulatory sequences derived from Chlamydomonas reinhardtii |
| 07/11/2001 | EP1114865A1 Production of human parathyroid hormone |
| 07/11/2001 | EP1114863A2 Heregulins (HRGs), binding proteins of P185erb2 |
| 07/11/2001 | EP1114829A2 Alloferons - Immunomodulatory peptides |
| 07/11/2001 | EP1114827A1 Novel nucleic acid base pair |
| 07/11/2001 | EP1114680A1 White rot fungus and method for degrading dioxins by using the same |
| 07/11/2001 | EP1114189A1 Recombinant newcastle disease virus rna expression systems and vaccines |
| 07/11/2001 | EP1114175A1 Fermentation medium and method for producing alpha,omega-alkanedicarboxylic acids |
| 07/11/2001 | EP1114174A1 Process for making polycarboxylic acids |
| 07/11/2001 | EP1114172A1 Transfer method for specific cellular localisation of nucleic acids |
| 07/11/2001 | EP1114168A2 Uracil permease from arabidopsis as herbicidal target gene |
| 07/11/2001 | EP1114166A1 Method for down-regulating osteoprotegerin ligand activity |
| 07/11/2001 | EP1114165A1 Aspergillus tubigensis polygalacturonase |
| 07/11/2001 | EP1114164A1 Atp synthase subunit homolog |